Phibro Animal Health Quarterly Cash Flow Statement
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Phibro Animal Health free cash flow
In the quarter ended Jun 30, 2026, Phibro Animal Health generated $24.1 million of operating cash flow and spent $18.9 million on capital expenditures. That left free cash flow of $5.2 million, a free-cash-flow margin of 1.3% of revenue. Free cash flow was down 35.7% from the prior year's $8.1 million.
Phibro Animal Health returned $4.9 million to shareholders through dividends, equal to 93% of free cash flow. Free cash flow covered dividend payments 1.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
Phibro Animal Health cash flow statement (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 21.71M | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M | 6.97M | 752.00K | 8.40M | 1.27M | -8.02M |
| Net Income growth (YoY) | +26.05% | +15.06% | +762.14% | +280.32% | +2190.43% | +148.42% | +150.00% | — | -93.46% | -16.30% | -82.33% | -307.86% |
| Depreciation & Amortization | 13.35M | 12.45M | 12.89M | 12.83M | 12.41M | 12.62M | 11.57M | 9.00M | 9.20M | 9.20M | 8.91M | 8.87M |
| Stock-Based Compensation | 413.00K | 411.00K | 434.00K | 339.00K | 179.00K | 179.00K | 180.00K | 179.00K | 179.00K | 135.00K | 80.00K | 81.00K |
| Change in Working Capital | -39.26M | -27.65M | -36.38M | -19.75M | -38.13M | 9.15M | -45.68M | 4.37M | 8.31M | -11.56M | 11.16M | 9.08M |
| Operating Cash Flow | 24.09M | 16.21M | 19.35M | 9.30M | 21.27M | 43.15M | 3.08M | 12.62M | 28.43M | 11.41M | 31.56M | 16.20M |
| Capital Expenditures | -18.87M | -15.32M | -11.10M | -13.81M | -13.14M | -7.75M | -7.82M | -9.58M | -13.07M | -9.73M | -10.96M | -7.48M |
| Investing Cash Flow | -16.45M | -16.81M | -17.18M | -21.01M | -7.03M | -18.25M | -260.47M | -2.93M | -9.11M | 1.13M | -24.86M | -15.35M |
| Dividends Paid | -4.87M | -4.87M | -4.86M | -4.86M | -4.86M | -4.87M | -4.86M | -4.86M | -4.86M | -4.86M | -4.86M | -4.86M |
| Financing Cash Flow | -1.61M | -2.30M | -18.98M | 16.34M | -7.77M | -32.22M | 276.32M | -29.20M | 1.79M | 4.85M | -14.71M | 1.30M |
| Net Change in Cash | 6.49M | -557.00K | -17.28M | 4.73M | 7.68M | -6.72M | 15.24M | -18.78M | 20.39M | 17.25M | -10.18M | 1.87M |
| Free Cash Flow | 5.22M | 890.00K | 8.26M | -4.50M | 8.13M | 35.41M | -4.75M | 3.04M | 15.36M | 1.68M | 20.60M | 8.72M |
This table shows 12 quarterly periods of Phibro Animal Health's cash flow statement, from Q4 2026 back to Q1 2024, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PAHC's reporting calendar. What is a cash flow statement?